Description
Overview
Triple-agonist (LY3437943) targeting GLP-1, GIP, and glucagon receptors. Studied for hepatic lipid metabolism and energy homeostasis pathways unavailable to dual or single agonists.
Research Applications
- Triple incretin agonist
- Hepatic lipid metabolism research
- Aggressive metabolic regulation model
- Body composition studies
Research use only. Not for human consumption. By purchasing you affirm you are a qualified researcher and accept full responsibility for handling and use.



Reviews
There are no reviews yet.